Skip to main content
. 2011 Jan;24(1):71–109. doi: 10.1128/CMR.00030-10

FIG. 4.

FIG. 4.

Single-target inhibitors that have reached the clinic (and their relations). (A) Actinonin; (B) BB83698; (C) LBM415; (D) triclosan; (E) GSK FabI inhibitor; (F) AFN-1252; (G) CG400549; (H) MUT37307; (I) iclaprim; (J) trimethoprim.